Comparative Efficacy of Dexamethasone and Tranexamic Acid in Reducing Bleeding, Edema, and Ecchymosis After Rhinoplasty: A Systematic Review and Meta-Analysis

Clicks: 3
ID: 337965
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #122 of 125 articles by views in Aesthetic Surgery Journal Open Forum

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 125 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Rhinoplasty carries risks such as edema, ecchymosis, and bleeding. Techniques to reduce these include medical treatments (corticosteroids such as dexamethasone, tranexamic acid [TXA], and herbal remedies) and surgical modifications. TXA minimizes blood loss, while dexamethasone reduces inflammation and swelling. Although effective, the systemic risks of TXA remain unclear. We aimed to compare the efficacy of dexamethasone and TXA in intraoperative bleeding and early postoperative edema and ecchymosis management in rhinoplasty. We searched for relevant articles up to May 2025 from PubMed, Scopus, and Web of Science. Two independent reviewers extracted data from the selected studies, including baseline information, outcomes, operative duration, complications, drug dosage, administration route, timing of doses, postoperative assessment intervals, mean intraoperative blood loss, edema scores, and ecchymosis scores. We collected 1,944 records after excluding 2,661 duplicates. Screening identified 37 entries eligible for inclusion. Dexamethasone significantly reduced ecchymosis scores (mean difference [MD] -0.92, p<0.001); however, its effects were transient (p=0.002). TXA was comparable to dexamethasone in reducing ecchymosis (p=0.129). Dexamethasone reduced edema scores (MD -0.583, p<0.001), although the effects diminished over time (MD 0.024, p=0.019). TXA showed slightly greater edema reduction than dexamethasone (MD -0.386, p=0.043). Bleeding reduction was similar between TXA and dexamethasone (MD -40.18, p=0.4108). Dexamethasone and TXA reduce early postoperative ecchymosis, edema, and bleeding post-rhinoplasty; however, their effects wane over time. Dexamethasone reduces ecchymosis and edema, whereas TXA may show stronger anti-edematous effects; neither is superior for bleeding reduction. Although their safety profiles appear favorable, the optimal dosing and administration need further study.
Reference Key
openalex_W7224990753 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal Aesthetic Surgery Journal Open Forum
Year 2026
DOI
10.1093/asjof/ojag220
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.